" class="no-js "lang="en-US"> Breast Cancer Archives - Medtech Alert
Friday, December 13, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics

BPGbio, a leading AI-powered biopharma that focuses on oncology, neurology, and rare diseases, today announced […]

Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC

Epic Sciences, a privately held diagnostics company, has completed a $24 million Series G which […]

MOLLI Surgical Launches Breakthrough Products to Simplify Breast Cancer Surgery and Deliver a Better Patient Experience

MOLLI Surgical, the company that is pushing the boundaries of precision surgery for breast cancer, […]

Novartis Trial Shows Benefit in Patients with Breast Cancer

Novartis today announced positive topline results from an interim analysis of NATALEE, a Phase III […]

Cantargia Treats First Triple-Negative Breast Cancer Patient in Randomized Phase II Part of TRIFOUR Trial

Cantargia today reported that, following positive results in the lead-in phase of the clinical phase […]

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program

Radiology Imaging Associates (RIA), a division of RadNet, has announced that it has started the […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more